COVID-19 and Pneumonia: Increased Risk for Individuals with Intellectual and Developmental Disabilities during the Pandemic

Adults with intellectual and developmental disabilities (IDD) are more likely to develop pneumonia than adults without IDD. This brief describes the implications of higher rates of pneumonia among individuals with IDD for increased risk of serious complications (including death) from COVID-19

COVID-19 Trends Among Adults with Intellectual and Developmental Disabilities (IDD) Living in Residential Group Homes in New York State through July 10, 2020

While COVID-19 case rates increased between April 10, 2020 and July 10, 2020 for both groups, from April 10 to May 1, the case rate increased by 2.5 times for people with IDD, from 2,225 to 5,544 cases per 100,000, but only increased by 1.6 times for New York State, from 886 to 1,584 cases per 100,000

Less Worthy Lives? We Must Prioritize People with Intellectual and Developmental Disabilities in COVID-19 Vaccine Allocation

Individuals with developmental and intellectual disability should prioritized during COVID-19 vaccination allocation

The philosophical writings of Richard Burthogge,

"Reprints from first editions in the possession of the Harvard university library. All are printed entire save the Essay upon reason." - Pref.With facsimiles of original title-pages: (1) Organum vetus & novum. Or, A discourse of reason and truth ... London, S. Crouch, 1678. (2) An essay upon reason, and the nature of spirits ... London, J. Dunton, 1694. (3) Of the soul of the world; and of particular souls. In a letter to Mr. Lock, occasioned by Mr. Keil's reflections upon an essay lately published concerning reason. By the author of that essay ... London, D. Brown, 1699.Mode of access: Internet

Developmental stages of developmental screening: Steps to implementation of a successful program.

Through the use of 2-stage screening strategies, research studies have shown that autism spectrum disorders and other developmental disabilities can now be detected reliably and with greater validity and in children as young as 18 months of age. Screening and diagnostic practices in the medical and educational arena lag far behind clinical research, however, with the average patient age at time of diagnosis being 3 to 6 years. We discuss the challenges of instituting universal developmental screening as part of pediatric care and present 2 models of existing or planned programs of early screening for autism spectrum disorder and developmental disability (1 in a community-based setting and 1 in a pediatric setting), and discuss the pros and cons of the different strategies